Actualizaciones regulatorias
Novedades regulatorias de FDA, EMA, TGA y organismos globales
#CILOSTAZOL ×
Actualizaciones regulatorias
3 sept 2026•1 min de lectura
FDA Approves Apotex CILOSTAZOL (ANDA077030)
FDA has approved Apotex's oral cilostazol tablets (50 mg and 100 mg) under ANDA 077030, adding a generic phosphodiesterase‑3 inhibitor to the market.
Actualizaciones regulatorias
30 ago 2026•1 min de lectura
FDA Approves CILOSTAZOL Tablets (ANDA077831)
FDA has approved Chartwell Rx's ANDA077831 for oral CILOSTAZOL tablets in 50 mg and 100 mg strengths, with labeling updates approved in 2016.